ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM
Latent chronic ascorbic acid deficiency provokes in guinea pigs a metabolic disorder in the liver, causing an impaired cholesterol transformation to its principal catabolic product, bile acids. This metabolic disorder induces hypercholesterolemia and accumulation of cholesterol in the liver and slow...
Gespeichert in:
Veröffentlicht in: | Annals of the New York Academy of Sciences 1975-09, Vol.258 (1), p.410-421 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 421 |
---|---|
container_issue | 1 |
container_start_page | 410 |
container_title | Annals of the New York Academy of Sciences |
container_volume | 258 |
creator | Ginter, Emil |
description | Latent chronic ascorbic acid deficiency provokes in guinea pigs a metabolic disorder in the liver, causing an impaired cholesterol transformation to its principal catabolic product, bile acids. This metabolic disorder induces hypercholesterolemia and accumulation of cholesterol in the liver and slows the release of cholesterol from the circulation. Ascorbic acid probably intervenes into the biosynthesis of bile acids at the stage of 7 alpha-hydroxylation of the cholesterol nucleus. High doses of ascorbic acid significantly stimulate cholesterol transformation to bile acids in guinea pigs and decrease plasma cholesterol concentration in humans. |
doi_str_mv | 10.1111/j.1749-6632.1975.tb29299.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_83170622</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>83170622</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4740-9be0d23b8d79bb7dcdbd87fb1d3d26b7db61ffcab8ca7dd1822f9b48b357e6733</originalsourceid><addsrcrecordid>eNqVkE9PgzAYhxujmXP6EUyIB29g_wClXgwwtmEYJGPGeGooLcnm5ibd4vbtBVmMV3tp0t_7e970AeAOQQs152FpIWoz03UJthCjjrUTmGHGrMMZ6P9G56APIaWmxzC5BFdaLyFE2LNpD_QQdKGNYB84fh5msyAODT-Mh0acGuEkS6J8Hs2yxPDToRHESdSF02juB1kS59NrcFEVK61uTvcAvIyieTgxk2wch35ilja1ocmEghIT4UnKhKCylEJ6tBJIEond5kG4qKrKQnhlQaVEHsYVE7YniEOVSwkZgPuOu603n3uld3y90KVarYoPtdlr7hFEoYtxM_jYDZb1RutaVXxbL9ZFfeQI8tYZX_JWDG_F8NYZPznjh6Z8e9qyF2sl_1R_JDX5U5d_LVbq-A8yT9_8vCOYHWGhd-rwSyjqd958s6m8pmPukBHOg-CZu-QbqTiGEA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>83170622</pqid></control><display><type>article</type><title>ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Ginter, Emil</creator><creatorcontrib>Ginter, Emil</creatorcontrib><description>Latent chronic ascorbic acid deficiency provokes in guinea pigs a metabolic disorder in the liver, causing an impaired cholesterol transformation to its principal catabolic product, bile acids. This metabolic disorder induces hypercholesterolemia and accumulation of cholesterol in the liver and slows the release of cholesterol from the circulation. Ascorbic acid probably intervenes into the biosynthesis of bile acids at the stage of 7 alpha-hydroxylation of the cholesterol nucleus. High doses of ascorbic acid significantly stimulate cholesterol transformation to bile acids in guinea pigs and decrease plasma cholesterol concentration in humans.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1111/j.1749-6632.1975.tb29299.x</identifier><identifier>PMID: 1060410</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aged ; Animals ; Ascorbic Acid - administration & dosage ; Ascorbic Acid - pharmacology ; Ascorbic Acid Deficiency - complications ; Ascorbic Acid Deficiency - metabolism ; Bile Acids and Salts - metabolism ; Cholesterol - metabolism ; Cholesterol - pharmacology ; Cholesterol, Dietary ; Female ; Guinea Pigs ; Humans ; Hypercholesterolemia - etiology ; Kinetics ; Liver - drug effects ; Liver - metabolism ; Male ; Middle Aged ; Spleen - drug effects ; Spleen - metabolism</subject><ispartof>Annals of the New York Academy of Sciences, 1975-09, Vol.258 (1), p.410-421</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4740-9be0d23b8d79bb7dcdbd87fb1d3d26b7db61ffcab8ca7dd1822f9b48b357e6733</citedby><cites>FETCH-LOGICAL-c4740-9be0d23b8d79bb7dcdbd87fb1d3d26b7db61ffcab8ca7dd1822f9b48b357e6733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1749-6632.1975.tb29299.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1749-6632.1975.tb29299.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1060410$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ginter, Emil</creatorcontrib><title>ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>Latent chronic ascorbic acid deficiency provokes in guinea pigs a metabolic disorder in the liver, causing an impaired cholesterol transformation to its principal catabolic product, bile acids. This metabolic disorder induces hypercholesterolemia and accumulation of cholesterol in the liver and slows the release of cholesterol from the circulation. Ascorbic acid probably intervenes into the biosynthesis of bile acids at the stage of 7 alpha-hydroxylation of the cholesterol nucleus. High doses of ascorbic acid significantly stimulate cholesterol transformation to bile acids in guinea pigs and decrease plasma cholesterol concentration in humans.</description><subject>Aged</subject><subject>Animals</subject><subject>Ascorbic Acid - administration & dosage</subject><subject>Ascorbic Acid - pharmacology</subject><subject>Ascorbic Acid Deficiency - complications</subject><subject>Ascorbic Acid Deficiency - metabolism</subject><subject>Bile Acids and Salts - metabolism</subject><subject>Cholesterol - metabolism</subject><subject>Cholesterol - pharmacology</subject><subject>Cholesterol, Dietary</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>Humans</subject><subject>Hypercholesterolemia - etiology</subject><subject>Kinetics</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Spleen - drug effects</subject><subject>Spleen - metabolism</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1975</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkE9PgzAYhxujmXP6EUyIB29g_wClXgwwtmEYJGPGeGooLcnm5ibd4vbtBVmMV3tp0t_7e970AeAOQQs152FpIWoz03UJthCjjrUTmGHGrMMZ6P9G56APIaWmxzC5BFdaLyFE2LNpD_QQdKGNYB84fh5msyAODT-Mh0acGuEkS6J8Hs2yxPDToRHESdSF02juB1kS59NrcFEVK61uTvcAvIyieTgxk2wch35ilja1ocmEghIT4UnKhKCylEJ6tBJIEond5kG4qKrKQnhlQaVEHsYVE7YniEOVSwkZgPuOu603n3uld3y90KVarYoPtdlr7hFEoYtxM_jYDZb1RutaVXxbL9ZFfeQI8tYZX_JWDG_F8NYZPznjh6Z8e9qyF2sl_1R_JDX5U5d_LVbq-A8yT9_8vCOYHWGhd-rwSyjqd958s6m8pmPukBHOg-CZu-QbqTiGEA</recordid><startdate>197509</startdate><enddate>197509</enddate><creator>Ginter, Emil</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197509</creationdate><title>ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM</title><author>Ginter, Emil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4740-9be0d23b8d79bb7dcdbd87fb1d3d26b7db61ffcab8ca7dd1822f9b48b357e6733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1975</creationdate><topic>Aged</topic><topic>Animals</topic><topic>Ascorbic Acid - administration & dosage</topic><topic>Ascorbic Acid - pharmacology</topic><topic>Ascorbic Acid Deficiency - complications</topic><topic>Ascorbic Acid Deficiency - metabolism</topic><topic>Bile Acids and Salts - metabolism</topic><topic>Cholesterol - metabolism</topic><topic>Cholesterol - pharmacology</topic><topic>Cholesterol, Dietary</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>Humans</topic><topic>Hypercholesterolemia - etiology</topic><topic>Kinetics</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Spleen - drug effects</topic><topic>Spleen - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ginter, Emil</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ginter, Emil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>1975-09</date><risdate>1975</risdate><volume>258</volume><issue>1</issue><spage>410</spage><epage>421</epage><pages>410-421</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>Latent chronic ascorbic acid deficiency provokes in guinea pigs a metabolic disorder in the liver, causing an impaired cholesterol transformation to its principal catabolic product, bile acids. This metabolic disorder induces hypercholesterolemia and accumulation of cholesterol in the liver and slows the release of cholesterol from the circulation. Ascorbic acid probably intervenes into the biosynthesis of bile acids at the stage of 7 alpha-hydroxylation of the cholesterol nucleus. High doses of ascorbic acid significantly stimulate cholesterol transformation to bile acids in guinea pigs and decrease plasma cholesterol concentration in humans.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>1060410</pmid><doi>10.1111/j.1749-6632.1975.tb29299.x</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0077-8923 |
ispartof | Annals of the New York Academy of Sciences, 1975-09, Vol.258 (1), p.410-421 |
issn | 0077-8923 1749-6632 |
language | eng |
recordid | cdi_proquest_miscellaneous_83170622 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Aged Animals Ascorbic Acid - administration & dosage Ascorbic Acid - pharmacology Ascorbic Acid Deficiency - complications Ascorbic Acid Deficiency - metabolism Bile Acids and Salts - metabolism Cholesterol - metabolism Cholesterol - pharmacology Cholesterol, Dietary Female Guinea Pigs Humans Hypercholesterolemia - etiology Kinetics Liver - drug effects Liver - metabolism Male Middle Aged Spleen - drug effects Spleen - metabolism |
title | ASCORBIC ACID IN CHOLESTEROL AND BILE ACID METABOLISM |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A30%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ASCORBIC%20ACID%20IN%20CHOLESTEROL%20AND%20BILE%20ACID%20METABOLISM&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Ginter,%20Emil&rft.date=1975-09&rft.volume=258&rft.issue=1&rft.spage=410&rft.epage=421&rft.pages=410-421&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1111/j.1749-6632.1975.tb29299.x&rft_dat=%3Cproquest_cross%3E83170622%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=83170622&rft_id=info:pmid/1060410&rfr_iscdi=true |